Kimura Y, Pham N M, Yasuda K, Nanri A, Kurotani K, Kuwahara K, Akter S, Sato M, Hayabuchi H, Mizoue T
Department of Nutrition and Life Science, Faculty of Life Science and Biotechnology, Fukuyama University, Hiroshima, Japan.
Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Eur J Clin Nutr. 2015 Apr;69(4):462-6. doi: 10.1038/ejcn.2014.257. Epub 2014 Dec 3.
BACKGROUND/OBJECTIVES: Although adipokines and insulin resistance are known to be correlated with body fatness, it is unclear whether they are independently related to weight gain experience. We examined the associations of serum adipokines and marker of insulin resistance with past weight gain during adulthood by taking the degree of attained body mass index (BMI) level into consideration.
SUBJECTS/METHODS: Subjects were 399 Japanese municipal employees, aged ⩾ 30 years, who participated in a health survey. Serum adipokines were measured using a Luminex suspension bead-based multiplexed array. Weight change during adulthood was calculated as the difference between measured current weight and recalled weight at the age of 20 years. Multiple regression was performed to calculate mean adipokine levels and homeostasis model assessment of insulin resistance (HOMA-IR) according to weight gain (< 5 kg, 5-9.9 kg, or ⩾ 10 kg) with adjustment for current BMI.
Weight gain from the age of 20 years was significantly and positively associated with leptin levels even after adjustment for current BMI (P for trend < 0.001), whereas it was significantly and inversely associated with adiponectin levels in a BMI-adjusted model among subjects aged ⩾ 40 years (P for trend=0.03). Weight gain was associated with HOMA-IR in a BMI-unadjusted model (P for trend < 0.001), but this association was largely attenuated after adjustment for BMI. Resistin, plasminogen activator inhibitor-1 and visfatin were not associated with past weight gain.
Results suggest that a large weight gain during adulthood is associated with higher leptin and lower adiponectin levels independently of the degree of attained BMI level.
背景/目的:尽管已知脂肪因子和胰岛素抵抗与体脂相关,但它们是否与体重增加经历独立相关尚不清楚。我们通过考虑达到的体重指数(BMI)水平,研究了血清脂肪因子和胰岛素抵抗标志物与成年期既往体重增加之间的关联。
对象/方法:对象为399名年龄≥30岁的日本市政雇员,他们参与了一项健康调查。使用基于Luminex悬浮微珠的多重检测阵列测量血清脂肪因子。成年期体重变化计算为当前测量体重与回忆的20岁时体重之间的差值。进行多元回归以计算根据体重增加(<5kg、5 - 9.9kg或≥10kg)调整当前BMI后的平均脂肪因子水平和胰岛素抵抗稳态模型评估(HOMA-IR)。
即使在调整当前BMI后,20岁起的体重增加与瘦素水平仍显著正相关(趋势P<0.001),而在年龄≥40岁的受试者中,在BMI调整模型中体重增加与脂联素水平显著负相关(趋势P = 0.03)。在未调整BMI的模型中体重增加与HOMA-IR相关(趋势P<0.001),但在调整BMI后这种关联大幅减弱。抵抗素、纤溶酶原激活物抑制剂-1和内脂素与既往体重增加无关。
结果表明,成年期大量体重增加与较高的瘦素水平和较低的脂联素水平独立相关,与达到的BMI水平无关。